NovaBay Pharmaceuticals, Inc.
NBY
$0.6001
$0.00010.02%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 25.07% | 26.34% | 11.99% | 9.16% | 9.13% |
| Total Depreciation and Amortization | 7.02% | -0.78% | -6.62% | -5.33% | -26.29% |
| Total Amortization of Deferred Charges | -48.28% | 28.87% | 328.67% | -- | -- |
| Total Other Non-Cash Items | -65.40% | -45.76% | -16.61% | -15.25% | 15.49% |
| Change in Net Operating Assets | -37.41% | -192.71% | 263.73% | -177.03% | -181.24% |
| Cash from Operations | -16.29% | -4.10% | 44.33% | 22.66% | 30.36% |
| Capital Expenditure | 68.42% | 43.75% | 91.58% | 92.08% | 83.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 5,700.00% | 6,731.25% | 1,217.89% | 1,151.49% | 83.04% |
| Total Debt Issued | -83.33% | -100.00% | -100.00% | -- | -- |
| Total Debt Repaid | -35.01% | -249.87% | -1,185.49% | -- | -1,303.81% |
| Issuance of Common Stock | 449.56% | -- | -53.55% | -66.82% | -66.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 36.46% | 99.32% | 99.32% | -- | -- |
| Cash from Financing | -21.47% | -80.41% | -123.33% | -72.29% | -58.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -57.58% | 301.37% | 2,056.25% | -- | -- |
| Net Change in Cash | -10.34% | -614.52% | -588.96% | -35.52% | -14.67% |